Search the Library

Abstract: This Blending Team Product combines a CME course and Patient Simulation to create a unique forum to provide practical guidance for physicians and other clinicians in effective Motivational Interviewing techniques that will facilitate conversations with patients to address health risk behaviors. The CME course, “Talking to Patients about Health Risk Behaviors,” guides physicians, nurses, and other clinicians through practical skills building and technique development using videos to model effective communication, while the interactive Patient Simulation allows for real time testing and reinforcement of these skills in the clinical setting. Physicians can earn a maximum of 1.5 AMA PRA Category 1 Credits via the CME course; Nurses can earn 1.5 ANCC Contact Hours. There is also an unaccredited module for other providers to use to enrich their clinical best practices.

Abstract:

This NIDA/SAMHSA Blending Team Product is an online resource hub providing information and tools related to a variety of technology-assisted care for substance use disorders. Technology-assisted care is a rapidly evolving field focused on adding technology-based elements to a practitioner’s “toolkit” as a supplement and complement to their treatment repertoire. These elements take many forms and formats, including audio, video, animations, and/or other forms of multimedia. It also may use information from medical records or physiological data capture devices, and may be interactively customized or tailored to an individual user’s needs. Treatment practices administered via technology-based interventions include: Cognitive Behavioral Therapy; Community Reinforcement Approach (CRA); Contingency Management; Motivational Enhancement; Motivational Interviewing; and Screening, Brief Intervention and Relapse Prevention.

The SUDTECH site is a collaborative product providing information, videos, training, and other resource information for implementing technology assisted treatments/care to improve the quality and reach of treatment services for persons with substance use disorders. It includes curricula, research studies and links, video interviews with practitioners who use technology-assisted care, information on administrative and other considerations for implementing this type of approach, program models, and much more.

SUDTECH focuses primarily on two technology-assisted care models: Therapeutic Education System (TES) and Computer-Based Training for Cognitive Behavioral Therapy (CBT4CBT). A National Drug Abuse Treatment Clinical Trials Network protocol evaluated the effectiveness of TES (CTN-0044), a web-based psychosocial intervention for substance use disorder, and found that it doubled the odds of abstinence among clients who tested positive for substances, improved retention, and suggested that TES could be effectively substituted for a portion of face-to-face counseling and produce better outcomes. CBT4CBT is a web-based program that teaches a variety of skills to help people reduce their substance use. While not studied in the CTN, a randomized controlled trial of 77 individuals seeking outpatient treatment found that participants assigned to CBT4CBT submitted significantly more urine specimens testing negative for any type of drugs, especially cocaine, and tended to have longer continuous periods of abstinence during treatment.

Related protocols: CTN-0044

Abstract:

The NIDA Clinical Trials Network conducted the multisite “HIV Rapid Testing and Counseling” study (protocol CTN-0032) to examine the efficacy of on-site rapid testing and risk-reduction counseling in increasing the receipt of results and reducing HIV risk behaviors of patients in substance abuse treatment programs. Research showed that offering this testing in substance abuse treatment centers substantially increased receipt of HIV test results and identified persons who were unaware of their HIV infection. Testing may be implemented for less than $40 per rapid HIV test and is cost-effective. Substance use treatment patients are receptive to on-site testing and are more likely to get tested than if they are referred to another agency for testing.

The National Institute on Drug Abuse (NIDA) and the Substance Abuse Mental Health Services Administration’s Addiction Technology Transfer Network have partnered to promote the dissemination of the results from drug abuse research. This collaboration (the blending of research and practice) has produced numerous research-based training workshops and products designed specifically for substance abuse treatment providers. The HIV Rapid Testing Blending Product can be found online at http://www.nattc.org/rapidtesting and includes: video interviews with researchers, treatment providers, and clients about the value of onsite rapid HIV testing; a fact sheet that provides details about the need for onsite testing and the outcomes of the CTN protocol; and a web guide that provides links to valuable testing and other implementation resources.

Related protocols: CTN-0032

Abstract:

[Note: the CD version of this product is no longer available. Factsheets and links to additional resources may still be available at the link provided.]

This new CD-ROM features copies of the three previous buprenorphine-related Blending Products (Buprenorphine Treatment, Short-Term Opioid Withdrawal Using Buprenorphine, and Buprenorphine Treatment for Young Adults), bundled together with the new Prescription Opioid Addiction Treatment Study (POATS) product.

The new POATS product includes a clinician training program and manual, PowerPoint presentation, resource list, fact sheets, and additional materials to help clinicians implement and promote buprenorphine treatment in their practices.

This CD-ROM compilation includes resources in a variety of formats, including training manuals (PDFs), PowerPoint presentations, short video clips, research articles, and other resources.

Abstract:

Motivational Incentives: Positive Reinforcers to Enhance Successful Treatment Outcomes (MI:PRESTO) is an interactive on-line course that focuses on the process of adopting Motivational Incentives in a clinical setting. By design, this course builds upon the Addiction Technology Transfer Center Network’s Technology Transfer Conceptual Model. Highlighted within this model is a multidimensional process that promotes the use of an innovation, in this case Motivational Incentives.

This free, self-guided, online learning tool assists Clinical Supervisors and other behavioral healthcare practitioners to learn and experience how to utilize the 7 Principles of Motivational Incentives introduced in PAMI, to facilitate the adoption of Motivational Incentives as an effective evidence-based practice aimed at reducing drug abuse and promoting positive outcomes for patients.

Related protocols: CTN-0006, CTN-0007

Abstract:

THIS PRODUCT IS NO LONGER AVAILABLE. The Motivational Incentives Implementation Software (MIIS) is available at no cost. This platform, developed by the National Institute on Drug Abuse, provides the mechanisms to: assist researchers, clinicians, and counselors in utilizing and applying Motivational Incentives for treating patients with substance use disorders; and maintain information about clinic patients as well as in the implementation and calculation of incentives based on the defined parameters. MIIS is secure, easy to use, and easy to implement. The user interface allows patient information and activities to be stored and can manage patient appointments and supply detailed reports about patient progress. Patients are automatically awarded draws as an incentive for attendance and abstinence. MIIS can be configured to select prizes and provide draws in varying escalation schedules that are sensitive to patient history of compliance and relapse. The software also maintains a record of prizes awarded to patients.

This product has been combined with two other MI Blending Team Products, PAMI and MI:PRESTO to form a “Motivational Incentives (MI) Package.” MIIS has been discontinued; the other two products are available here: https://collaborativeforhealth.org/bettertxoutcomes/.

Related protocols: CTN-0006, CTN-0007

Abstract:

Researchers involved in the CTN protocols NIDA-CTN-0006 and NIDA-CTN-0007 (Motivational Incentives for Enhanced Drug Abuse Recovery in Drug Free Clinics and Methadone Clinics) have shown that motivational incentive programs using low-cost reinforcement (prizes, vouchers, clinic privileges, etc.), delivered in conjunction with onsite urine screening promotes higher rates of treatment retention and abstinence from drug abuse. This Blending Team product focuses on informing the field about successful approaches in the use of motivational incentives (also referred to as contingency management). The package includes an instructional CD-ROM, loaded with a video featuring conversations from top researchers to clinicians to patients in the field of addiction and recovery; sample documents that are customizable to your needs; PowerPoint presentations; research articles; and various additional resources. The PAMI Product was distributed to Research Utilization Committee (RUC) members in May 2007. It can also be downloaded from the ATTC web site.

This product was updated in 2011, providing tools designed to build awareness of Motivational Incentives as an effective therapeutic strategy within the addiction treatment field. It has been combined with two other MI Blending Team Products, MI:PRESTO and MIIS, to form a “Motivational Incentives (MI) Package.” MIIS has been discontinued; the other two products can be found here: https://collaborativeforhealth.org/bettertxoutcomes/.

Related protocols: CTN-0006, CTN-0007

Abstract:

The Buprenorphine Treatment for Young Adults Blending Team designed a training package which highlights the findings of protocol CTN-0010, “Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults,” which compared longer-term versus short-term buprenorphine/naloxone treatment in an outpatient setting.

The 3-hour training program examines the prevalence of and treatment admission rates for nonmedical use of opioids among young adults; provides an overview of opioid use among young adults; explores and increases understanding of the results of new research on using buprenorphine to treat opioid addiction in young adults; and describes the implications of these findings for the treatment of opioid addiction in young adults.

Related protocols: CTN-0010

Abstract:

Note: This product is no longer available.

Accelerating the dissemination of research-based drug abuse treatment findings into community-based practice is a key priority for NIDA and represents the core mission of the NIDA/SAMHSA Blending Initiative. This initiative is NIDA’s most recent and innovative effort to accelerate the dissemination of research-based drug abuse treatment findings into community-based practice. NIDA’s partnership with SAMHSA has led to the creation of Blending Teams, which are composed of members from SAMHSA’s Addiction Technology Transfer Center (ATTC) Network and NIDA researchers who have worked closely to collectively develop Blending Team Products. This set of CD-ROMs combines all five products developed through the NIDA/SAMHSA Blending Initiative into a single package: Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals; Short-Term Opioid Withdrawal Using Buprenorphine; Treatment Planning M.A.T.R.S: Utilizing the Addiction Severity Index (ASI) to Make Required Data Collection Useful; Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA:STEP); and Promoting Awareness of Motivational Incentives (PAMI).

Each of the disks contains training materials, PowerPoint presentations, and other resources needed to facilitate the adoption of science-based interventions in community settings. All of these materials are in the public domain and are inteded for wide dissemination. Copies of this CD set were sent to all Node PIs and Research Utilization Committee (RUC) representatives in Fall 2007.

Related protocols: CTN-0001, CTN-0002, CTN-0005, CTN-0006, CTN-0007

Abstract:

Researchers involved in protocol NIDA-CTN-0005, “MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse,” found that MI improved both client attendance and retention during the first four weeks of outpatient care. The researchers also discovered that the development and maintenance of MI skills was a challenge for the counselors engaged in the study. Participating in training was not sufficient preparation and, instead, on-going feedback and mentoring were needed in order for most counselors to use MI consistently. This package of products is meant to be used in the context of such clinical supervision or mentoring — it is not a training package itself and should not serve as a substitute for intensive basic training in MI. Instead, it is a collection of resources and toolkits to be used to help enhance both counselor MI skills and the quality and nature of the mentoring process. It?s a win-win for clients and agency staff alike.

The first section of the package includes briefing materials to assist in introducing the “Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency” (MIA:STEP) products to State or County authorities, treatment agency administrators, and clinical supervisors. Included are: an announcement template for marketing MIA:STEP, an executive summary of the MI assessment, an overview of the MIA:STEP Toolkit, and a brief interview with an agency treatment director. The rest of the package includes a description of the MI assessment interview, results of the NIDA clinical trials research, a number of teaching tools, an interview tape rating guide, demonstration tapes, rating forms, learning plans and a training curriculum for preparing supervisors in the use of the MIA:STEP package. Three CDs accompany the print version of the MIA:STEP, featuring audio tracks from two sample interviews in English and one in Spanish (these tracks are not available for download online).

The MIA:STEP package was updated in August 2007 with several editorial changes (including corrections, simplifications of some of the interview rating forms, and revisions to the training curriculum in section I of the package).

Related protocols: CTN-0005

Abstract:

In 2002 tablet formulations of buprenorphine were approved by the FDA for the treatment of opiate addiction. The National Drug Abuse Treatment Clinical Trials Network (CTN) has implemented and completed two clinical trials comparing a short-term opioid withdrawal using buprenorphine versus clonidine in both inpatient and outpatient settings (protocols NIDA-CTN-0001 and NIDA-CTN-0002). The results of these trials suggest that buprenorphine is substantially better than clonidine for opioid detoxification.

|In order to prepare the field to effectively integrate this treatment method into their current practice, NIDA formed a Blending Team to develop this package of training materials to instruct providers on how to implement the procedures evaluated through these research protocols. This training was designed to provide a broad overview of the medication, its effects, and the role of non-physician practitioners in providing and supporting the treatment of individuals receiving this medication.

|The training package includes PowerPoint training slides, a Trainer’s Manual, and a marketing brochure. The training manual is designed to support a half-day face-to-face training to review the results from the CTN research protocols. It then provides instruction for implanting these protocols into treatment settings including methods of evaluation and induction, the taper schedule, and the use of ancillary medications during treatment. Adaptation of these materials to meet the needs of the specific target audience is expected and supported by the materials themselves (for example, detailed speaker notes, not a word-for-word script, are provided for maximum flexibility). The training requires approximately four hours, and trainers should plan to have a laptop, LCD projector, and flip chart paper or easel/white board on hand for the training.

Related protocols: CTN-0001, CTN-0002

Abstract:

The Treatment Planning M.A.T.R.S. (formerly “S.M.A.R.T. Treatment Planning”) product is a 6-hour continuing education curriculum package addressing how to transform required “paperwork” into clinically useful information. The Addiction Severity Index (ASI) is one of the most widely used tools for the assessment of substance use-related problems. Addiction counselors working in community-based treatment centers administer the ASI yet often fail to use findings to identify client problems, develop individualized treatment plans, and make referrals matched to client needs. Intake workers, counselors, supervisors, and managers often view the ASI assessment as time consuming and not clinically useful. From a program management perspective, supervisors and administrators often do not utilize treatment plans to monitor treatment outcomes and/or client retention. This course will review how to use the ASI to integrate these clinical processes.

|This curriculum was developed through the NIDA/SAMHSA-ATTC Blending Initiative including staff from CSAT’s Addiction Technology Transfer Center (ATTC) Network and NIDA researchers. It was revised in Spring 2007. For information on how to obtain a print copy of this product, call 816-482-1100.

Abstract:

The primary goal of this Blending Team product is to create awareness and build knowledge about buprenorphine among multidisciplinary addiction professionals. The materials include information designed to increase motivation for bringing buprenorphine to local communities, as well as information about what to expect when someone is treated with this medication. Additionally, materials discuss legislation that permits office-based buprenorphine treatment, the science of addiction, the mechanism of buprenorphine, patient selection issues, and various patient, counseling, and therapeutic issues.

The Buprenorphine Awareness Blending Team package contains: the Training Guide for the 6-hour training, an informational brochure about the product, and two CDs. The first CD contains the PowerPoint presentation for the training, electronic copies of the Training Guide and brochure, and a draft version of an annotated bibliography about Buprenorphine. The second CD contains a video entitled, “Put Your Smack Down! A Video about Buprenorphine” (used in Module VI of the training) and an online course developed by the Central East ATTC called “Buprenorphine Treatment of Opioid Addiction: A Guide for Counselors.” Each of these items can also be downloaded from the ATTC web site.